Published in Emerg Infect Dis on April 01, 2004
Human babesiosis. Infect Dis Clin North Am (2008) 2.12
Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev (2011) 1.47
Update on babesiosis. Interdiscip Perspect Infect Dis (2009) 1.39
Transmission and epidemiology of zoonotic protozoal diseases of companion animals. Clin Microbiol Rev (2013) 1.23
Importance of nonenteric protozoan infections in immunocompromised people. Clin Microbiol Rev (2010) 0.92
Babesiosis acquired through blood transfusion, California, USA. Emerg Infect Dis (2009) 0.86
In vitro cultivation of a zoonotic Babesia sp. isolated from eastern cottontail rabbits (Sylvilagus floridanus) on Nantucket Island, Massachusetts. J Clin Microbiol (2005) 0.83
Human Babesiosis: Pathogens, Prevalence, Diagnosis and Treatment. Curr Clin Microbiol Rep (2015) 0.78
Identification and Characterization of the Rhoptry Neck Protein 2 in Babesia divergens and B. microti. Infect Immun (2016) 0.77
Bumped kinase inhibitor prohibits egression in Babesia bovis. Vet Parasitol (2015) 0.77
Multiplex assay detection of immunoglobulin G antibodies that recognize Babesia microti antigens. Clin Vaccine Immunol (2012) 0.76
Comparison of Babesia microti Real-Time Polymerase Chain Reaction Assays for Confirmatory Diagnosis of Babesiosis. Am J Trop Med Hyg (2016) 0.75
Diagnosis and management of human babesiosis. Trop Parasitol (2015) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci (1996) 56.57
Babesiosis. Clin Microbiol Rev (2000) 3.97
Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med (2000) 3.56
A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med (1996) 2.37
Human babesiosis: an emerging tick-borne disease. Int J Parasitol (2000) 2.36
Human babesiosis. Ann Trop Med Parasitol (1998) 2.24
Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis (2003) 2.12
Infection with a babesia-like organism in northern California. N Engl J Med (1995) 2.00
Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev (2003) 1.95
Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis (2001) 1.89
Persistent parasitemia after acute babesiosis. N Engl J Med (1998) 1.81
Babesiosis in Washington State: a new species of Babesia? Ann Intern Med (1993) 1.71
Babesia microti infection in man: evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg (1978) 1.60
A subtropical case of human babesiosis. Acta Trop (1997) 1.54
A case of babesiosis in man in the United States. Am J Trop Med Hyg (1968) 1.44
Babesiosis in splenectomized adults. Review of 22 reported cases. Am J Med (1984) 1.40
Endemic babesiosis in another eastern state: New Jersey. Emerg Infect Dis (2003) 1.28
Babesiosis in Wisconsin: a potentially fatal disease. Am J Trop Med Hyg (1995) 1.28
Naturally acquired babesiosis in a reindeer (Rangifer tarandus tarandus) herd in Great Britain. Parasitol Res (2002) 1.23
Treatment of transfusion-transmitted babesiosis by exchange transfusion. N Engl J Med (1980) 1.21
Transfusion-transmitted babesiosis in Washington State: first reported case caused by a WA1-type parasite. J Infect Dis (1997) 1.13
A fatal case of human babesiosis in Portugal: molecular and phylogenetic analysis. Trop Med Int Health (2003) 1.13
Infection of the Mongolian gerbil with the cattle piroplasm Babesia divergens. Nature (1979) 1.05
Cultivation and phylogenetic characterization of a newly recognized human pathogenic protozoan. J Infect Dis (1994) 1.05
Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California. Transfusion (2002) 1.04
Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N Engl J Med (2002) 1.02
Antigenic, phenotypic and molecular characterization confirms Babesia odocoilei isolated from three cervids. J Wildl Dis (2000) 0.99
Exchange transfusion for malaria and Babesia infection. Transfus Med Rev (2002) 0.97
Phylogenetic relationships of human and wildlife piroplasm isolates in the western United States inferred from the 18S nuclear small subunit RNA gene. Parasitology (2000) 0.93
Treatment of babesiosis in asplenic patients. JAMA (1981) 0.89
Separation and recombination of Babesia divergens and Ehrlichia phagocytophila from a field case of redwater from Eire. Vet Rec (1976) 0.88
Babesiosis: persistence in the face of adversity. Trends Parasitol (2003) 0.86
Serological prevalence and isolation of Babesia odocoilei among white-tailed deer (Odocoileus virginianus) in Texas and Oklahoma. J Wildl Dis (1989) 0.84
Life-threatening babesiosis in an asplenic patient treated with exchange transfusion, azithromycin, and atovaquone. Heart Lung (1999) 0.80
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol (2009) 12.98
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 4.23
Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS One (2008) 3.94
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis (2011) 3.78
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect Dis (2011) 3.71
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis (2013) 3.56
Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med (2002) 3.41
Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. Am J Med (2003) 3.23
Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb Drug Resist (2006) 3.11
Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis (2012) 3.06
HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy. Curr HIV Res (2007) 2.78
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med (2011) 2.76
Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains. Antimicrob Agents Chemother (2005) 2.72
Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis (2006) 2.48
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis (2007) 2.43
Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol (2010) 2.32
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother (2007) 2.28
Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis (2013) 2.27
Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis (2003) 2.12
PCR as a confirmatory technique for laboratory diagnosis of malaria. J Clin Microbiol (2006) 1.98
Hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in the United States--September-October 2009. Clin Infect Dis (2011) 1.95
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation (2006) 1.94
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine (2011) 1.88
Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease. J Infect Dis (2007) 1.88
Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J Clin Microbiol (2003) 1.87
LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers). Diagn Microbiol Infect Dis (2007) 1.80
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations. J Antimicrob Chemother (2005) 1.75
Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol (2005) 1.75
Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529. Expert Rev Vaccines (2003) 1.74
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents (2004) 1.73
Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents. J Clin Microbiol (2005) 1.71
Nocardia veterana, a new emerging pathogen. J Clin Microbiol (2003) 1.70
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations. J Antimicrob Chemother (2004) 1.70
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol (2005) 1.70
Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004). Diagn Microbiol Infect Dis (2006) 1.67
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay. Am J Respir Crit Care Med (2011) 1.66
Sexual behavior and reproductive health among HIV-infected patients in urban and rural South Africa. J Acquir Immune Defic Syndr (2008) 1.66
Comparison of strain typing results for Clostridium difficile isolates from North America. J Clin Microbiol (2011) 1.65
In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn, Wyeth) formulation. Diagn Microbiol Infect Dis (2008) 1.65
Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis (2004) 1.65
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates. Diagn Microbiol Infect Dis (2004) 1.63
Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms. Diagn Microbiol Infect Dis (2005) 1.61
Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J Clin Microbiol (2008) 1.60
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60
Strongyloidiasis in transplant patients. Clin Infect Dis (2009) 1.60
Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. Liver Transpl (2006) 1.59
NmcA carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America. Emerg Infect Dis (2003) 1.55
Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients. Clin Infect Dis (2007) 1.51
Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA. Clin Chem (2004) 1.50
Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. AIDS Res Hum Retroviruses (2012) 1.50
Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point. J Immunol (2009) 1.49
Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009. Clin Infect Dis (2011) 1.48
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006. Antimicrob Agents Chemother (2009) 1.47
Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults. Crit Care Med (2015) 1.45
International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol (2006) 1.45
Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa. J Int AIDS Soc (2011) 1.42
Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States Hospitals. Antimicrob Agents Chemother (2011) 1.42
Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J Mol Diagn (2011) 1.41
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2008) 1.38
Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent. J Clin Microbiol (2007) 1.36
Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. PLoS One (2011) 1.35
Structure-activity relationship of synthetic toll-like receptor 4 agonists. J Biol Chem (2003) 1.35
'Candidatus Protochlamydia amoebophila', an endosymbiont of Acanthamoeba spp. Int J Syst Evol Microbiol (2005) 1.35
Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics. AIDS (2010) 1.34
Initial results from a longitudinal international surveillance programme for anidulafungin (2003). J Antimicrob Chemother (2004) 1.33
Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates. Diagn Microbiol Infect Dis (2004) 1.33
Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis (2010) 1.29
CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II. Microbiology (2005) 1.28
Antimicrobial-resistant strains of Clostridium difficile from North America. Antimicrob Agents Chemother (2012) 1.27
Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptide. Int J Antimicrob Agents (2004) 1.27
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens. Diagn Microbiol Infect Dis (2005) 1.26
Molecular and morphologic characterization of a Cryptosporidium genotype identified in lemurs. Vet Parasitol (2003) 1.26
Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol (2005) 1.26
Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: validation report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis (2005) 1.25
Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS (2013) 1.25
Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob Agents Chemother (2006) 1.25
Molecular characterisation of Babesia canis canis and Babesia canis vogeli from naturally infected European dogs. Vet Parasitol (2002) 1.23
The third described case of transfusion-transmitted Babesia duncani. Transfusion (2011) 1.21
Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates. J Antimicrob Chemother (2004) 1.20
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn Microbiol Infect Dis (2005) 1.20
Convenient selective differential broth for isolation of vancomycin-resistant enterococcus from fecal material. J Clin Microbiol (2004) 1.19
Coccidioidomycosis acquired in Washington State. Clin Infect Dis (2012) 1.19
Identification of Leishmania spp. by molecular amplification and DNA sequencing analysis of a fragment of rRNA internal transcribed spacer 2. J Clin Microbiol (2011) 1.18
Expanded geographical distribution of the N family of Mycobacterium tuberculosis strains within the United States. J Clin Microbiol (2004) 1.18
Evidence of multiple virulence subtypes in nosocomial and community-associated MRSA genotypes in companion animals from the upper midwestern and northeastern United States. Clin Med Res (2010) 1.18
Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn Microbiol Infect Dis (2006) 1.18
Rapid identification of commonly encountered Candida species directly from blood culture bottles. J Clin Microbiol (2003) 1.17
Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med (2010) 1.17
Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti. Transfusion (2005) 1.16